
Cell Therapy for Anthracycline Cardiomyopathy Safe, Feasible
- Wellness
- Admin COUPONS
- October 3, 2020
In a small phase 1 study, administration of allogeneic bone marrow-derived mesenchymal stromal cells was safe and feasible in patients with anthracycline-induced cardiomyopathy heart failure. Medscape Medical News
%%item_READ_MORE…_button%%